Brian Stegman, MD
Interventional Cardiology · St Cloud, MNNPI 1447425160
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (49.3%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 23 manufacturers reported payments, led by Edwards Lifesciences at 50.5% of the total. 2025 is the largest year on record at $182,733, more than ten times the $11,380 reported in 2019. Among interventional cardiology clinicians in MN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 942 payments — averaging $623.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Edwards Lifesciences$297K
- Medtronic$107K
- Boston Scientific$69K
- Angiodynamics, Inc.$26K
- Inquis Medical, Inc.$21K
- Abiomed$19K
- plus $47K from 17 others
Across 369 payments — averaging $4620.43 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Edwards Lifesciences$577K
- Cardiovascular Systems Inc.$572K
- Boston Scientific$363K
- Inari Medical, Inc.$151K
- Abbott$19K
- Angiodynamics, Inc.$16K
- plus $7K from 2 others
What the payments were for
- Consulting fees$228,82939%
- Speaking & faculty fees$289,74849%
- Travel & lodging$42,2127%
- Food & beverage$26,3134%
- Education$160%
- Entertainment$470%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Edwards Lifesciences | 408 | $296,796 |
| Medtronic(2 entities) | 240 | $107,340 |
| Boston Scientific | 88 | $69,425 |
| Angiodynamics, Inc. | 31 | $26,082 |
| Inquis Medical, Inc. | 17 | $20,836 |
| Abiomed | 44 | $19,382 |
| Inari Medical, Inc. | 27 | $18,552 |
| Cardiovascular Systems Inc. | 25 | $11,876 |
| Abbott | 26 | $11,851 |
| Ancora Heart, Inc. | 9 | $2,213 |
| Shockwave Medical, Inc | 7 | $870 |
| ZOLL Circulation Inc | 2 | $807 |
| Stryker | 1 | $625 |
| Cardiac Dimensions, Inc. | 3 | $130 |
| Reflow Medical Inc | 1 | $81 |
| Terumo Medical Corporation | 4 | $64 |
| Patterson Companies, Inc. | 1 | $50 |
| Opsens Inc. | 1 | $47 |
| Heartflow, Inc. | 2 | $36 |
| E.r. Squibb & Sons, L.L.C. | 2 | $34 |
| Philips North America LLC | 1 | $29 |
| GE HealthCare | 1 | $26 |
| Cordis US CORP. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Edwards SAPIEN 3 Transcatheter Heart Valve$111,730
- PASCAL$104,736
- COREVALVE EVOLUT R$82,008
- Sentinel$38,309
- AlphaVac$23,782
- Aventus$20,537
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$20,211
- Diamondback Coronary$19,881
- Impella$18,254
- FLOWTRIEVER CATHETER, S$17,958
- CT THROMBECTOMY SYSTEM KIT$17,958
- CoreValve Evolut$7,354
- GENERAL - THERAPIES$7,143
- General - CT_IC$6,250
- ISLEEVE$3,000
- AccuCinch$2,046
- AngioVac$1,882
- EVOQUE$1,531
- Coronary Orbital Atherectomy System$1,144
- SAPIEN 3 Ultra RESILIA$1,113
How this compares
$587,165 in reported general payments places this provider in the 95th percentile of 84 interventional cardiology providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 52 | $72,477 |
| JardianceEmpagliflozin | 32 | $35,248 |
| Repatha SureclickEvolocumab | 31 | $33,111 |
| Metoprolol Succinate | 121 | $2,255 |
| Atorvastatin Calcium | 91 | $1,577 |
| Ezetimibe | 22 | $1,303 |
| Ranolazine ErRanolazine | 11 | $872 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 38 | $713 |
| Rosuvastatin Calcium | 56 | $609 |
| Furosemide | 99 | $506 |
| ClopidogrelClopidogrel Bisulfate | 37 | $400 |
| Lisinopril | 42 | $380 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 16 | $344 |
| Losartan Potassium | 38 | $343 |
| Carvedilol | 36 | $332 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in St Cloud
- Jacob DutcherSt Cloud$123K
- Wade SchmidtSt Cloud$9K
- Thom DahleSaint Cloud$1.1M
- Stephen KiddSaint Cloud$607K
- Emmanouil BrilakisMinneapolis$548K
- Wesley PedersenMinneapolis$493K
- Michael ManolesMinneapolis$201K
- Jay TraverseMinneapolis$198K
- Robert WilsonMinneapolis$176K
- Yale WangMinneapolis$168K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.